CABERGOLINE, 0.5mg, break. tab.

STD DORACABG5TB

Valid Article

18.8 - Medicines for disorders of the pituitary hormone system
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N04BC06
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)

This combination does not exist.

Add article to list

   

Add Kit To Wishlist

   

CABERGOLINE

Therapeutic Action

Indications

Inhibition of lactation or cessation of lactation in case of intrauterine fetal death or neonatal death

Instructions for use

Pharmacological methods are more effective than non-pharmacological methods in inhibiting lactation during the first week after delivery.

Storage

Below 25ºC ‐ Protect from sunlight ‐ Protect from humidity